Please provide your email address to receive an email when new articles are posted on . Three preclinical models were used to evaluate GraftJacket Acellular Periosteum Replacement Scaffold (Wright ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global acellular dermal matrices market is estimated to be valued at US$ 6,483.6 million in 2020 and is expected to exhibit a CAGR ...

Dublin, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The "Acellular Dermal Matrix Implant Market - A Global and Regional Analysis - Analysis and Forecast, 2024-2030" report has been added to ...

(HealthDay) -- Acellular dermal matrices provide good outcomes for patients undergoing breast reconstruction following mastectomy, but the human AlloDerm matrix has a higher seroma rate than porcine ...

November 3, 2009 (Seattle, Washington) — A new study of the acellular dermal matrix AlloDerm (LifeCell), presented here at Plastic Surgery 2009: American Society of Plastic Surgeons Annual Meeting, ...

A phase II pharmacokinetic/pharmacogenetic (PK/PG) study using fixed-dose capecitabine in metastatic breast cancer (MBC). Background: Outcomes after total skin ...

Please provide your email address to receive an email when new articles are posted on . In a literature review of various skin substitutes, the plastic surgery principle of replacing like tissue with ...

April 27, 2009 — Treating diabetic foot ulcers with an acellular matrix (AM) skin graft resulted in faster and more complete healing than standard treatment, according to the results of a randomized ...

CENTENNIAL, Colo., Aug. 11, 2021 /PRNewswire/ -- AlloSource ®, one of the largest allograft providers in the U.S. creating innovative cellular and tissue products to help surgeons heal their patients, ...

Chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure sores, represent a major global health challenge owing to impaired tissue regeneration, persistent inflammation and high ...

Evaluation of the stage IB designation of the 7th edition of the AJCC Staging System. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text ...

The concerns of the current available scaffolds include unforeseeable cell–biomaterial interactions, uneven degradation of the biomaterial, inflammatory reaction and limited cell seeding efficiency.